|
????????-5?PDE5???????????????????????Erectile Dysfunction?ED??????????PDE5????????????????????????????
???????? ?????????????Vardenafil????????????PDE5??????????????????????????????????????????? ?????????? ????PDE5????????????????????????????????????15?30?????????????????????????????????????????????????????????????????????????????? ????????? ??????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????? ??? vs ??PDE5??? ???????????????????????????????????????????????????????PDE5??????????????????????????????????????????????? ????Sildenafil???????????ED?PDE5????????????4?6??????????Tadalafil????????????????36??????[???]??????????????????????????????????????? ????Vardenafil?????PDE5?????????????????????????????????????????????????????ED???????????????????????????????????PDE5?????????????????? ????? 1.Carson, C. C., Rajfer, J., Eardley, I., Carrier, S., Denne, J., & Walker, D. J. (2004). The efficacy and safety of tadalafil: an update. BJU international, 93(9), 1276-1281. 2.Becher, E. F., & Sildenafil Study Group. (2000). Efficacy and safety of sildenafil citrate in the treatment of erectile dysfunction in patients with ischemic heart disease. The American journal of cardiology, 86(2), 131-136. |
